Skip to Content

APO MI 30 (Mirtazapine 30 mg)

Pill imprint APO MI 30 has been identified as Mirtazapine 30 mg.

Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; post traumatic stress disorder (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.